This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Alston, S. J. Articles by Braun, M. Search for Related Content PubMed PubMed Citation Articles by Alston, S. J. Articles by Braun, M. Related Collections Infectious Disease & Immunity Related AAP Red Book topics: Fungal Diseases Tinea Corporis (Ringworm of the... Social Bookmarking                         What's this?

PEDIATRICS Vol. 111 No. 1 January 2003, pp. 201-203

EXPERIENCE AND REASON

Persistent and Recurrent Tinea Corporis in Children Treated With Combination Antifungal/ Corticosteroid Agents

Sharonda J. Alston, MD^*, Bernard A. Cohen, MD^*,, Marisa Braun, MD

^* Johns Hopkins University School of Medicine
Division of Pediatric Dermatology, Baltimore, MD 21287
University of Maryland School of Medicine Baltimore, MD 21201

Background. Combination antifungal/corticosteroid preparations are widely used by nondermatologists in the treatment of superficial fungal infections in patients of all ages. Over half of the prescriptions written for the most commonly used combination agent clotrimazole 1%/betamethasone diproprionate 0.05% cream (Lotrisone, Schering, Kenilworth, NJ) were prescribed for children younger than 4 years old. Our pediatric dermatology division has recently encountered a series of children with recurrent or persistent tinea corporis, especially tinea faciei, treated initially with combination antifungal/corticosteroid cream.

Methods. All children evaluated for tinea corporis in a university hospital pediatric dermatology clinic from January through June 2001 were identified from the clinic registry for a retrospective chart review. Response to therapy was confirmed by telephone survey and/or follow-up visits at least 1 month after clearing of infection.

Results. Six children ranging in age from 4 to 11 years were evaluated for tinea corporis in a pediatric dermatology clinic at our institution during the 6-month period. All 6 children were diagnosed clinically by their pediatrician with tinea corporis and initially treated with clotrimazole 1%/betamethasone diproprionate 0.05% cream for 2 to 12 months. In our pediatric dermatology clinic, patients had their diagnosis confirmed with a positive potassium hydroxide preparation and were treated with one of several oral or topical antifungal agents with clearing of all tinea infections.

Conclusion. The use of combination clotrimazole 1% cream/betamethasone diproprionate 0.05% cream (Lotrisone) for the treatment of tinea corporis may be associated with persistent/recurrent infection.

Key Words: tinea corporis • persistent • recurrent • combination antifungal • corticosteroid cream • therapy

---

Received for publication May 7, 2002; Accepted Aug 14, 2001.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				Combination Antifungal-Corticosteroid Cream: Still Failing After All These Years Journal Watch Pediatrics and Adolescent Medicine, March 10, 2003; 2003(310): 13 - 13. [Full Text]

				Combination Antifungal-Corticosteroid Cream: Still Failing After All These Years Journal Watch Dermatology, January 29, 2003; 2003(129): 6 - 6. [Full Text]